Immunology: Current Research
Open Access

HIV; Zinc and Selenium; Patients; Infection

Introduction

Human immunological disorder Virus (HIV) infection may be a major ill health within the world and HIV infected people square measure susceptible to deficiency disease thanks to many factors as well as inadequate nutrient intake (anorexia, gastrointestinal complications like nausea and instinctive reflex, oral and passage sores), nutrient loss (malabsorption and diarrhea), metabolic alteration (increased macromolecule flip over and changes in carboxylic acid metabolism), and drug-nutrient interactions [1].

Functional standing and survival of HIV-infected patient’s square measure littered with their biological process conditions. The essential role of biological process support and highly active anti-retroviral therapy (HAART) in HIV-infected people has been approved. American Dietetic Association recommends biological process support as a region of the care provided to HIV-infected patients [2].

Trace parts particularly zinc (Zn) and selenium (Se) square measure vital for maintaining a healthy system. Deficiency disease will declines T cells generation and depresses body substance and cell-mediated immunity. Chemical element deficiency additionally has many medical implications as well as impaired reaction. The most route of HIV transmission in Persia is via injection drug use (IDU) and there's no information regarding biological process standing among this population [3].

Method

This study could be an annual cross-sectional, descriptive analytic survey conducted at Iranian Referral HIV/AIDS Centre connected to Tehran University of Medical Sciences. This center is supported by Iranian Ministry of Health and Medical Education and provides free services like Para-clinical, clinical and consultation for every volunteer who is also in danger of infection by HIV or the other sexually transmitted unwellness [4]. The management subjects were age matched healthy males associated with HIV infected people (who attended HIV infected patients), with none medical drawback at the time of the study or history of any chronic unwellness and with negative anti-HIV protein take a look at [5].

During patient's interview, demographic information as well as social, activity and case history were collected within the designed forms. Biological process standing of every patient was assessed mistreatment measurement parameters. Weight make up my mind to the closest 0.1 weight unit (kg) mistreatment adult balance and standing height make up my mind to the closest one centimeter (Cm). Body Mass Index (BMI) was calculated mistreatment the subsequent formula: BMI = weight (kg) divided by [Height (m)]2. BMI (normal range 18.5-27 kg/m2based on age) of but 16, 16-16.9 and 17-18.4 kg/m2 were thought-about as severe, moderate and gentle deficiency disease severally. All patients were asked regarding weight changes throughout past six months. Up to 10% weight loss was thought-about important and over 10% weight loss was thought-about severe weight loss [6].

Data was analyzed mistreatment SPSS (Chicago, IL, USA) package, version 11.5. statistical distribution of knowledge were assessed mistreatment Kolmogorov-Smirnov take a look at and freelance sample t-test was wont to compare numeric variables like age, weight, high, albumin, bodily fluid Zn and Se levels between HIV-infected patients and healthy subjects [7]. Variations between bodily fluid Zn and Se concentrations from counseled cutoffs were evaluated by onesample t-test. Analysis of variance was wont to compare bodily fluid Zn and Se concentrations between teams that were categorized supported deficiency disease severity [8]. For determination of variations between severity and prevalence of deficiency disease between HIV infected people and healthy cluster, chi-square and fisher-exact take a look at were used [9]. Correlations between information were evaluated mistreatment pearson correlation. Descriptive statistics (cross-tabs) followed selectively of chi-square and risk was used for generation of odds magnitude relation and confidence interval. P-values of but 0.05 were thought-about as important [10].

Results

One hundred HIV-infected adult patients with the mean age of 35.4 ± 7.8 years (range: 21-45 years old) and 100 healthy people with the mean age of 32.4 ± 7.8 years (range of 20-43 years old) completed this study. During this study 31% of injection drug users had a history of medication consumption like benzodiazepines, acetaminophencodeine, tramadol, antibiotics and non-steroidal medicinal drug medicine and 3% of them used seasoned medications. None of the HIV-infected patients had a history of alimentation or mineral supplementary consumption [11].

Significant and severe recent weight losses were detected in 7% and 5% of patients severally. Supported agency definition, 12% of the patients had wasting syndrome [12].

Patients with moderate deficiency disease had vital lower humor Zn and Se levels than non-depleted patients. Severe deficiency disease was a risk issue for Zn deficiency (Odds quantitative relation = 2.3 (95% confidence interval = 1.2-4.5 and P = 0.001) [13].

Discussion

In this study 77% of freshly diagnosed HIV-infected patients WHO weren't in advanced section of the unwellness were evaluated and based to own a point of deficiency disease.

Malnutrition could be a vital clinical drawback in HIV-infected people. During this population, wasting has been related to unwellness progression and magnified mortality [14].

Although deficiency disease is typically encountered at the advanced section or finish of the HIV-infection course, however, as seen in our study it's going to additionally occur within the initial stages of the HIV-infection additionally [15].

As reported in another study, wasting syndrome was present in about 12% of the patients. Throughout wasting in HIV infection, the body tries to compensate energy from obtainable sources like visceral proteins. Though traditional albumen concentration has been reported in HIV-infected patients, albumen levels in our patients were considerably less than those of the healthy subjects. Additionally the patients with wasting syndrome had vital lower albumen than the patients while not wasting [16].

Based on World Health Organization organic process recommendations for HIV infected persons, adequate nutrition is important for health and survival for all subjects despite HIV infection condition. Following presentation of the study results, organic process assessment could be a part of clinical assessment of HIV infected people. Patients and their family have guidance concerning maintain adequate healthy diet and nutrition care in our Centre. Additionally it's stressed that these patients ought to be taking daily counseled of relevant micronutrients through diet or supplements.

Conclusion

In conclusion deficiency disease and liquid body substance metal and Se deficiency area unit common in Iranian HIV-infected patients and early analysis of nutritionary standing of those subjects and providing applicable nutritionary support and mineral supplementation beside the precise anti-retroviral treatment area unit counseled.

1. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, et al. (1998) Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18: 80-85.

Indexed at, Google Scholar, Crossref

2. Kotler DP, Tierney AR, Want J, Pierson RN (1989) Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50: 444-447.

Indexed at, Google Scholar, Crossref

3. Sharpstone D, Ross H, Hancock M, Phelan M, Crane R ,et al. (1997) Indirect calorimetry, body composition and small bowel function in asymptomatic HIV-seropositive women. Int J STD AIDS 8: 700-703.

Indexed at, Google Scholar, Crossref

4. Edwards P, Wodak A, Cooper DA, Thompson IL, Penny R (1990) The gastrointestinal manifestations of AIDS. Aust N Z J Med 20: 141-148.

Indexed at, Google Scholar, Crossref

5. Zeitz M, Ullrich R, Schneider T, Kewenig S, Riecken E (1998) Mucosal immunodeficiency in HIV/SIV infection. Pathobiology 66: 151-157.

Indexed at, Google Scholar, Crossref

6. Razani J, Murphy C, Davidson TM, Grant I, McCutchan A (1996) Odor sensitivity is impaired in HIV-positive cognitively impaired patients. Physiol Behav 59: 877-881.

Indexed at, Google Scholar, Crossref

7. Grunfeld C, Feingold KR (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 327: 329-337.

Indexed at, Google Scholar, Crossref

8. Blaxhult A, Granath F, Lidman K, Giesecke J (1990) The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS4: 125-129.

Indexed at, Google Scholar, Crossref

9. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, et al. (2000) Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133: 348-355.

Indexed at, Google Scholar, Crossref

10. Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, et al. (1999) Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 84: 1268-1276.

Indexed at, Google Scholar, Crossref

11. Shetty PS, Jung RT, Watrasiewicz KE, James WPT (1979) Rapid turnover transport proteins: an index of subclinical protein-energy malnutrition. Lancet 2: 230-232.

Indexed at, Google Scholar, Crossref

12. Constans J, Pellegrin JL, Sergeant C, Simonoff M, Pellegrin I, et al. (1995) Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr 10: 392.

Indexed at Google Scholar, Crossref

13. Carr A, Samaras K, Burton S, Law M, Freund J, et al. (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: 51-58.

Indexed at, Google Scholar, Crossref

14. Lee PD, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, et al. (1996) A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 81: 2968-2975.

Indexed at, Google Scholar, Crossref

15. Paella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 338: 853-860.

Indexed at, Google Scholar, Crossref

16. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, et al. (1998) Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 18: 80-85.

Indexed at, Google Scholar, Crossref